Quantum
Home > Boards > US Listed > Biotechs >

Kadmon Holdings (KDMN)

KDMN RSS Feed 		Add KDMN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/26/2018 4:08:41 PM - Followers: 5 - Board type: Free - Posts Today: 0

Healthcare-Biotech company developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
Quantum
KDMN
Current Price
Volume:
Bid Ask Day's Range
KDMN Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KDMN News: Quarterly Report (10-q) 11/09/2018 04:45:19 PM
KDMN News: Current Report Filing (8-k) 11/09/2018 04:24:09 PM
KDMN News: Kadmon Provides Business Update and Reports Third Quarter 2018 Financial Results 11/09/2018 04:20:22 PM
KDMN News: Kadmon to Present at the Jefferies 2018 London Healthcare Conference 11/07/2018 09:00:00 AM
KDMN News: Kadmon Presents New Preclinical Data on its Immuno-Oncology Fusion Protein at SITC Annual Meeting 11/06/2018 08:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#32   * * $KDMN Video Chart 10-26-18 * * ClayTrader 10/26/18 04:08:41 PM
#31   KD025 just got Breakthrough Therapy Designation from the mcp4 10/17/18 02:22:12 PM
#30   MetLife Investment Advisors has acquired 37K more shares mcp4 10/15/18 03:43:48 PM
#29   Ouch. 52 week low. Not much mcp4 10/10/18 03:57:05 PM
#28   1.4M KDMN shares were just purchased by VHCP mcp4 09/05/18 07:09:00 AM
#27   HC Wainwright has given KDMN a "Buy" rating mcp4 08/24/18 01:50:17 PM
#26   duplicate mcp4 08/21/18 09:49:27 AM
#25   Zacks has rated Kadmon "buy" but contradicts their mcp4 08/21/18 09:49:26 AM
#24   New research paper is out regarding KD025, the mcp4 08/15/18 02:26:34 PM
#23   2Q 2018 10-K is out. mcp4 08/09/18 06:36:35 PM
#22   Annual meeting announced for July 27th at the mcp4 07/03/18 12:02:22 PM
#21   * * $KDMN Video Chart 06-12-18 * * ClayTrader 06/12/18 04:50:16 PM
#20   Zandy Forbes and Tom Shenk resigned per 8-K mcp4 05/30/18 08:50:39 PM
#19   10-Q for 1Q 2018 filed yesterday. Phase mcp4 05/09/18 12:26:13 PM
#18   May 3, 2018 suberizedwrx 05/03/18 12:37:11 PM
#17   Zacks just upgraded KDMN to buy, and notes mcp4 04/30/18 12:20:47 PM
#16   ROCK2 inhibitor KD025 was approved for Phase II mcp4 04/19/18 01:26:03 PM
#15   K-10 was released earlier this month. The mcp4 03/15/18 01:02:32 PM
#14   Huge buy orders coming in ATVrider 03/09/18 12:44:52 PM
#13   I hated the way it traded moving down cjstocksup 02/13/18 08:21:33 PM
#12   Possible bounce play. Bottom looks to be in. INTL 02/13/18 07:57:34 PM
#11   * * $KDMN Video Chart 02-13-18 * * ClayTrader 02/13/18 05:17:22 PM
#10   KDMN afterhours news: cjstocksup 02/12/18 04:26:08 PM
#9   Really not a whole lot going on. mcp4 01/30/18 11:24:51 AM
#8   quiet board for a stock that is running tayronachan 01/30/18 09:04:49 AM
#7   KDMN buy 3.56 stocktrademan 06/21/17 05:15:16 PM
#6   Watching T695 04/06/17 09:27:38 PM
#5   Another paper, all theory and in vitro work, mcp4 08/24/16 08:19:42 AM
#4   Preclinical paper for KD025, a ROCK2 inhibitor, for mcp4 08/21/16 01:59:57 AM
#3   Insider buying! Entered today. Good pipeline IMO. vortmaximum 07/28/16 07:09:03 PM
#2   KDMN IPO reduced to 6.3M shares at $12. mcp4 07/26/16 03:11:02 PM
#1   Kadmon shares are expected to price between $16 mcp4 07/26/16 09:17:55 AM
PostSubject
© 2018 InvestorsHub.com, Inc.